RaySearch Laboratories EBITDA vs. Profit Margin
| RAY-B Stock | SEK 200.00 0.40 0.20% |
For RaySearch Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of RaySearch Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well RaySearch Laboratories AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between RaySearch Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of RaySearch Laboratories AB over time as well as its relative position and ranking within its peers.
RaySearch |
RaySearch Laboratories Profit Margin vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining RaySearch Laboratories's current stock value. Our valuation model uses many indicators to compare RaySearch Laboratories value to that of its competitors to determine the firm's financial worth. RaySearch Laboratories AB is currently regarded as top stock in ebitda category among its peers. It also is currently regarded as top stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RaySearch Laboratories' earnings, one of the primary drivers of an investment's value.RaySearch Profit Margin vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
RaySearch Laboratories |
| = | 197.36 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
RaySearch Laboratories |
| = | (0.01) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
RaySearch Profit Margin Comparison
RaySearch Laboratories is currently under evaluation in profit margin category among its peers.
RaySearch Laboratories Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in RaySearch Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, RaySearch Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of RaySearch Laboratories' change in net profit over the period of time. It can combine multiple indicators of RaySearch Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
RaySearch Laboratories AB operates as a medical technology company that develops software solutions for cancer treatment in North America, Asia, Europe, and internationally. The company was founded in 2000 and is headquartered in Stockholm, Sweden. RaySearch Laboratories operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange. It employs 307 people.
RaySearch Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on RaySearch Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of RaySearch Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the RaySearch Laboratories' important profitability drivers and their relationship over time.
Use RaySearch Laboratories in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RaySearch Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RaySearch Laboratories will appreciate offsetting losses from the drop in the long position's value.RaySearch Laboratories Pair Trading
RaySearch Laboratories AB Pair Trading Analysis
The ability to find closely correlated positions to RaySearch Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RaySearch Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RaySearch Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RaySearch Laboratories AB to buy it.
The correlation of RaySearch Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RaySearch Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RaySearch Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RaySearch Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your RaySearch Laboratories position
In addition to having RaySearch Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Repeal Thematic Idea Now
Obamacare Repeal
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for RaySearch Stock Analysis
When running RaySearch Laboratories' price analysis, check to measure RaySearch Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RaySearch Laboratories is operating at the current time. Most of RaySearch Laboratories' value examination focuses on studying past and present price action to predict the probability of RaySearch Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RaySearch Laboratories' price. Additionally, you may evaluate how the addition of RaySearch Laboratories to your portfolios can decrease your overall portfolio volatility.